Woodley BioReg will be Presenting at the 9th Congress of the Pharmaceutical Industry in Poland from the 7th – 9th November. Dr Ash Ramzan, Principal Consultant will be addressing the congress and updating them on the latest regulatory and quality developments within the pharmaceutical industry. In particular on the developments for EU implementation of the Falsified Medicines Directive.
The congress is an excellent opportunity to keep up to date with new technological innovations, exchange of experiences, information and ideas with like-minded representatives from the pharmaceutical industry.
Dr Ash Ramzan’s article ‘The Falsified Medicines Directive– What does it really mean for stakeholders?’ has been published in the TOPRA Regulatory Rapporteur.